Dynavax Technologies Corp (DVAX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Dynavax Technologies Corp (DVAX) reports robust HEPLISAV-B sales, expands market share, and launches new strategic programs despite challenges.

Stock market today: Dow, S&P 500, Nasdaq futures tick down with Supreme Court tariff case, Tesla shareholder meeting in focus

The major gauges have reached a holding pattern in a volatile week with investors seeking firm news on tariffs, earnings and ...

New to The Street to Broadcast Show #696 on Bloomberg, Saturday, November 1, Featuring Synergy CHC (SNYR), FLOKI, American Rebel (AREB), Aeries Technology (AERT), and Laser ...

The show airs as sponsored programming and includes TV commercials for Laser Photonics, The Sustainable Green Team (OTC:SGTM), PetVivo Holdings, Inc. , and Synergy CHC Corp. NEW YORK CITY, NEW YORK / ...

Moderna Is Running Low on Cash. Its Earnings Are Thursday.

Analysts are expecting Moderna to report revenue of $880 million in the third quarter, according to FactSet. The consensus ...

AppLovin perks up as Q3 results, outlook top estimates

AppLovin (APP) shares perked up 3% during early post-market trading on Wednesday after its third quarter 2025 financial results and fourth quarter outlook surpassed expectations.

Viatris Q3 Earnings Preview: Eyes on debt, pipeline amid stock slump

Viatris (VTRS) is set to report Q3 results on Thursday, November 6, before the market opens. Analysts expect EPS of $0.62, ...

Moderna Q3 preview: What to expect

Get the latest on Moderna’s Q3 earnings, analyst forecasts, COVID-19 vaccine sales impact, and what could shape MRNA’s stock ...

Moderna Earnings: What To Look For From MRNA

Moderna beat analysts’ revenue expectations by 10.7% last quarter, reporting revenues of $142 million, down 41.1% year on ...